Abbott India Limited
ABBOTINDIA
주식 순위
#3028
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
주가
$284.73
시가총액
$6.05B
변동 (1일)
-0.41%
변동 (1년)
-17.16%
국가
IN
거래 Abbott India Limited (ABBOTINDIA)
카테고리
Healthcare
Abbott India Limited (ABBOTINDIA)의 수익
Jun 2026 기준 수익 TTM: $238.19M
Abbott India Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 $238.19M입니다. 2024년에 회사는 $194.01M의 수익을 올렸으며 이는 2023년의 수익 $155.00M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Abbott India Limited의 수익 기록 (2004 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $238.19M | 7.96% |
| 2025 | $220.63M | 13.72% |
| 2024 | $194.01M | 25.17% |
| 2023 | $155.00M | 8.97% |
| 2022 | $142.24M | 12.45% |
| 2021 | $126.49M | 18.71% |
| 2020 | $106.55M | 5.87% |
| 2019 | $100.64M | 5.44% |
| 2018 | $95.45M | 41.81% |
| 2017 | $67.31M | 12.04% |
| 2016 | $60.08M | 8.86% |
| 2015 | $55.19M | 39.00% |
| 2014 | $39.70M | 1.44% |
| 2012 | $39.14M | 15.33% |
| 2011 | $33.94M | 61.11% |
| 2010 | $21.06M | -16.67% |
| 2009 | $25.28M | 33.27% |
| 2008 | $18.97M | -26.36% |
| 2007 | $25.76M | 31.50% |
| 2006 | $19.59M | 3.19% |
| 2005 | $18.98M | -38.51% |
| 2004 | $30.87M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $33.60B | 14,004.37% |
US
|
|
| $17.74B | 7,346.49% |
US
|
|
| $8.70B | 3,552.08% |
US
|
|
| $5.95B | 2,397.14% |
US
|
|
| $21.39B | 8,879.40% |
CH
|
